NRIX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03

Harga $22.99

Kapitalisasi Pasar (MRQ) $2.38B

P/E (TTM) -6.6

EPS (TTM) $-3.46

Pendapatan (TTM) $37M

ROE (TTM) -80.3%

Rentang 52M $9–$28

NRIX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04

rentang

batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Tentang Nurix Therapeutics, Inc. - Common stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

Wikidata ↗

sektorHealthcare industriBiotechnology karyawan317 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06

Pendapatan$84M

2019-11-30 → 2025-11-30

EPS$-3.05

2021-11-30 → 2025-11-30

Arus Kas Bebas$-263M

2020-11-30 → 2025-11-30

Margin bersih-928.4%

2020-11-30 → 2025-11-30

Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik	NRIX	rata-rata 5T	Median Rekan	Kesimpulan
P/E (TTM)	-6.6rata-rata 5T ≈-5.9	≈-5.9	·	·
P/S (TTM)	64.8rata-rata 5T ≈22.9	≈22.9	50.1	Nilai wajar
P/B (MRQ)	5.9rata-rata 5T ≈2.7	≈2.7	4.5	Nilai wajar
Price / FCF (Harga / FCF)	-8.9rata-rata 5T ≈-7.4	≈-7.4	·	·
Price / Cash Flow (Harga / Arus Kas)	-9.4rata-rata 5T ≈-7.9	≈-7.9	·	·
Price / Tangible Book (Harga / Nilai Buku Berwujud)	4.3rata-rata 5T ≈2.7	≈2.7	·	·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik	NRIX	rata-rata 5T	Median Rekan	Kesimpulan
Margin Operasi (TTM)	-982.4%rata-rata 5T ≈-360.9%	≈-360.9%	-7718.9%	Tingkat teratas
EBITDA Margin (Margin EBITDA)	-340.2%rata-rata 5T ≈-360.9%	≈-360.9%	-7701.1%	Tingkat teratas
Pretax Margin (Margin Sebelum Pajak)	-314.0%rata-rata 5T ≈-343.2%	≈-343.2%	-525.2%	Lemah
Margin Laba Bersih (TTM)	-928.4%rata-rata 5T ≈-343.5%	≈-343.5%	-7584.4%	Tingkat teratas
ROA (TTM)	-60.6%rata-rata 5T ≈-36.2%	≈-36.2%	-37.6%	Lemah
ROE (TTM)	-80.3%rata-rata 5T ≈-50.2%	≈-50.2%	-43.8%	Lemah
ROIC	-53.2%rata-rata 5T ≈-47.2%	≈-47.2%	-39.9%	Lemah

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik	Tren 5 Tahun	NRIX	rata-rata 5T	Median Rekan	Kesimpulan
Rasio Lancar (MRQ)		6.3rata-rata 5T ≈5.2	≈5.2	14.6	Likuiditas rendah
Quick Ratio (Rasio Cepat)		2.9rata-rata 5T ≈2.7	≈2.7	10.3	Likuiditas rendah

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik	NRIX	rata-rata 5T	Median Rekan	Kesimpulan
Revenue YoY (Pendapatan YoY)	53.9%rata-rata 5T ≈44.2%	≈44.2%	·	·
Revenue CAGR 3Y (CAGR Pendapatan 3T)	29.5%rata-rata 5T ≈38.3%	≈38.3%	·	·
Revenue CAGR 5Y (CAGR Pendapatan 5T)	36.4%	·	·	·

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik	NRIX	rata-rata 5T	Median Rekan	Kesimpulan
EPS (Diluted)	$-3.05rata-rata 5T ≈$-3.00	≈$-3.00	·	·
Revenue / Share (Pendapatan / Saham)	$0.97rata-rata 5T ≈$1.00	≈$1.00	·	·
Cash Flow / Share (Arus Kas / Saham)	$-2.88rata-rata 5T ≈$-2.56	≈$-2.56	·	·
Cash / Share (Kas / Saham)	$2.43rata-rata 5T ≈$1.63	≈$1.63	·	·

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik	Tren 5 Tahun	NRIX	rata-rata 5T	Median Rekan	Kesimpulan
Asset Turnover (Perputaran Aset)		0.1rata-rata 5T ≈0.1	≈0.1	0.1	Tingkat teratas
Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.)		≈$264.9K	·	·	·

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14

Kejutan Rata-rata 3.0%

Laporan Berikutnya Okt 07, 2026

Periode	Laporan	EPS Aktual	EPS Estimasi	Kejutan
30 Juni 2026	Jul 7, 2026	$-0.81	$-0.73	-10.8%
31 Maret 2026		$-0.79	$-0.77	-2.7%
31 Des. 2025		$-0.82	$-0.89	7.7%
30 Sep. 2025		$-1.03	$-0.86	-20.0%
30 Juni 2025		$-0.52	$-0.74	30.1%
31 Maret 2025		$-0.67	$-0.78	14.0%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15

Laporan Laba Rugi 13

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue	$84M	$55M	$77M	$39M	$30M	$18M	$31M
R&D Expense	$317M	$222M	$189M	$184M	$116M	$66M	$45M
SG&A Expense	$53M	$46M	$43M	$38M	$31M	$16M	$8M
Operating Expenses	$370M	$268M	$232M	$222M	$148M	$83M	$53M
Operating Income	$-286M	$-213M	$-155M	$-184M	$-118M	$-65M	$-22M
Pretax Income	$-264M	$-193M	$-144M	$-180M	$-117M	$-64M	$-21M
Income Tax	$760.0K	$270.0K	$0	$0	$131.0K	$-21M	$239.0K
Net Income	$-264M	$-194M	$-144M	$-180M	$-117M	$-43M	$-22M
EPS (Basic)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·
EPS (Diluted)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·
Shares (Basic)	86,666,907	67,120,266	54,337,901	48,607,990	42,895,383	·	·
Shares (Diluted)	86,666,907	67,120,266	54,337,901	48,607,990	42,895,383	·	·
EBITDA	$-286M	$-213M	$-155M	$-184M	$-118M	$-65M	·

Neraca 21

Metrik	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$247M	$110M	$55M	$64M	$81M	$119M	$35M
Short-term Investments	·	·	·	$245M	$215M	$162M	$3M
Receivables	·	$0	·	$0	$6M	·	·
Prepaid Expense	$14M	$10M	$8M	$9M	$9M	$6M	$2M
Current Assets	$607M	$619M	$296M	$318M	$311M	$298M	$39M
PP&E (Net)	$22M	$18M	$17M	$17M	$11M	$7M	$4M
PP&E (Gross)	$60M	$52M	$43M	$37M	$26M	$20M	$15M
Accum. Depreciation	$38M	$35M	$26M	$20M	$15M	$13M	$11M
Other Non-current Assets	$7M	$3M	$4M	$4M	$3M	$177.0K	$147.0K
Total Assets	$688M	$669M	$356M	$417M	$477M	$396M	$44M
Accounts Payable	$11M	$11M	$6M	$5M	$7M	$3M	$2M
Current Liabilities	$86M	$96M	$87M	$71M	$66M	$45M	$16M
Capital Leases	$53M	$20M	$23M	$6M	$9M	·	·
Other Non-current Liabilities	·	·	·	·	·	$850.0K	$2M
Total Liabilities	$149M	$142M	$155M	$113M	$134M	$106M	$54M
Common Stock	$102.0K	$76.0K	$49.0K	$47.0K	$45.0K	$39.0K	$4.0K
Retained Earnings	$-1.00B	$-739M	$-545M	$-401M	$-221M	$-104M	$-60M
AOCI	$105.0K	$150.0K	$-655.0K	$-4M	$-608.0K	$87.0K	$-2.0K
Stockholders' Equity	$539M	$527M	$200M	$304M	$342M	$290M	$-58M
Liabilities + Equity	$688M	$669M	$356M	$417M	$477M	$396M	$44M
Shares Outstanding	101,807,484	75,870,718	48,718,552	47,172,299	44,664,371	38,864,872	3,595,334

Arus Kas 11

Metrik	2025	2024	2023	2022	2021	2020	2019
D&A	$9M	$9M	$8M	$5M	$3M	$2M	$2M
Stock-based Comp	$38M	$34M	$34M	$28M	$16M	$4M	$510.0K
Operating Cash Flow	$-249M	$-173M	$-81M	$-160M	$-84M	$-80.0K	$601.0K
CapEx	$14M	$9M	$8M	$12M	$6M	$5M	$2M
Investing Cash Flow	$148M	$-258M	$68M	$27M	$-108M	$-254M	$8M
Stock Issued	$0	$290M	$0	$19M	$150M	$218M	·
Net Stock Activity	$0	$290M	$0	$19M	$150M	$218M	·
Financing Cash Flow	$239M	$486M	$3M	$117M	$154M	$339M	$126.0K
Net Change in Cash	$137M	$55M	$-10M	$-15M	$-39M	$85M	$9M
Taxes Paid	·	·	·	·	·	$1.0K	$1.0K
Free Cash Flow	$-263M	$-182M	$-90M	$-172M	$-90M	$-5M	·

Profitabilitas 7

Metrik	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%	-364.7%	·
Net Margin	-314.9%	-354.9%	-187.0%	-466.9%	-393.9%	-242.7%	·
Pretax Margin	-314.0%	-354.4%	-187.0%	-466.9%	-393.5%	-357.9%	·
EBITDA Margin	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%	-364.7%	·
ROA	-39.0%	-37.8%	-37.3%	-40.4%	-26.9%	-19.6%	·
ROE	-53.6%	-42.8%	-66.3%	-55.8%	-32.7%	-14.5%	·
ROIC	-53.2%	-40.5%	·	-60.5%	-34.5%	-15.2%	·

Likuiditas & Solvabilitas 2

Metrik	Tren	2025	2024	2023	2022	2021	2020	2019
Current Ratio		7.0	6.5	3.4	4.5	4.7	6.7	·
Quick Ratio		2.9	1.1	0.6	4.4	4.6	6.3	·

Efisiensi 2

Metrik	Tren	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.1	0.1	0.2	0.1	0.1	0.1	·
Receivables Turnover		·	·	·	12.9	9.9	·	·

Per Saham 6

Metrik	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$5.29	$6.95	$4.12	$6.44	$7.66	$7.47	·
Revenue / Share	$0.97	$0.81	$1.42	$0.79	·	·	·
Cash Flow / Share	$-2.88	$-2.57	$-1.50	$-3.29	·	·	·
Cash / Share	$2.43	$1.45	$1.12	$1.37	$1.80	$3.07	·
Dividend / Share	$0.00	$0.00	·	·	·	$0.00	$0.00
EPS (TTM)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·

Tingkat Pertumbuhan 3

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	53.9%	-29.1%	99.3%	29.8%	67.0%	·	·
Revenue CAGR 3Y	29.5%	22.4%	62.9%	·	·	·	·
Revenue CAGR 5Y	36.4%	·	·	·	·	·	·

Valuasi (TTM) 10

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$84M	$55M	$77M	$39M	$30M	$18M	·
Net Income TTM	$-264M	$-194M	$-144M	$-180M	$-117M	$-43M	·
Market Cap	$1.80B	$1.68B	$303M	$584M	$1.29B	$1.66B	·
P/E	-5.8	-7.7	-2.3	-3.3	-10.6	·	·
P/S	21.4	30.8	3.9	15.1	43.3	93.0	·
P/B	3.3	3.2	1.5	1.9	3.8	5.7	·
P / Tangible Book	3.3	3.2	1.5	1.9	3.8	5.7	·
P / Cash Flow	-7.2	-9.7	-3.7	-3.7	-15.3	-20705.3	·
P / FCF	-6.8	-9.2	-3.4	-3.4	-14.3	-357.5	·
Earnings Yield	-17.2%	-13.0%	-42.6%	-29.9%	-9.5%	·	·

Laporan Laba Rugi 13

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$9M	$6M	$14M	$8M	$44M	$18M	$13M	$13M	$12M	$17M	$15M	$18M	$31M	$13M	$7M	$11M
R&D Expense	$88M	$84M	$83M	$86M	$78M	$70M	$67M	$55M	$49M	$50M	$50M	$48M	$46M	$46M	$46M	$48M
SG&A Expense	$16M	$15M	$14M	$13M	$14M	$12M	$11M	$12M	$12M	$12M	$11M	$11M	$12M	$10M	$9M	$10M
Operating Expenses	$103M	$99M	$97M	$99M	$92M	$81M	$78M	$67M	$61M	$62M	$60M	$58M	$57M	$56M	$55M	$58M
Operating Income	$-94M	$-92M	$-83M	$-91M	$-48M	$-63M	$-65M	$-55M	$-49M	$-45M	$-45M	$-40M	$-27M	$-43M	$-49M	$-47M
Pretax Income	$-90M	·	$-78M	$-86M	$-43M	$-56M	$-59M	$-49M	$-44M	$-41M	$-42M	$-37M	$-24M	$-41M	$-47M	$-46M
Income Tax	$-271.0K	$0	$0	$0	$760.0K	$0	$8.0K	$82.0K	$90.0K	$90.0K	$0	$0	$0	$0	$0	$0
Net Income	$-90M	$-87M	$-78M	$-86M	$-43M	$-56M	$-59M	$-49M	$-45M	$-42M	$-42M	$-37M	$-24M	$-41M	$-47M	$-46M
EPS (Basic)	$-0.81	$-0.79	$-0.83	$-1.03	$-0.52	$-0.67	$-0.74	$-0.67	$-0.71	$-0.76	$-0.77	$-0.68	$-0.45	$-0.75	$-0.85	$-0.90
EPS (Diluted)	$-0.81	$-0.79	$-0.83	$-1.03	$-0.52	$-0.67	$-0.74	$-0.67	$-0.71	$-0.76	$-0.77	$-0.68	$-0.45	$-0.75	$-0.85	$-0.90
Shares (Basic)	111,084,423	110,071,668	·	84,159,336	83,882,477	83,560,795	·	72,779,381	62,377,551	54,903,407	·	54,390,859	54,259,045	54,028,238	·	50,868,542
Shares (Diluted)	111,084,423	110,071,668	·	84,159,336	83,882,477	83,560,795	·	72,779,381	62,377,551	54,903,407	·	54,390,859	54,259,045	54,028,238	·	50,868,542
EBITDA	$-94M	$-92M	·	$-91M	$-48M	$-63M	·	$-55M	$-49M	$-45M	·	$-40M	$-27M	$-43M	·	$-47M

Neraca 20

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$68M	$71M	$247M	$78M	$84M	$76M	$110M	$99M	$117M	$50M	$55M	$42M	$59M	$34M	$64M	$48M
Short-term Investments	·	·	·	·	·	·	·	·	·	·	·	$217M	$222M	$244M	·	$297M
Receivables	·	·	·	·	$19M	·	·	·	·	·	·	$2M	·	·	·	·
Prepaid Expense	$13M	$14M	$14M	$12M	$11M	$14M	$10M	$8M	$7M	$7M	·	$7M	$9M	$11M	·	$10M
Current Assets	$456M	$554M	$607M	$441M	$515M	$564M	$619M	$456M	$450M	$251M	·	$268M	$290M	$288M	·	$355M
PP&E (Net)	$20M	$22M	$22M	$20M	$19M	$18M	$18M	$17M	$19M	$18M	·	$17M	$18M	$18M	·	$17M
PP&E (Gross)	$61M	$61M	$60M	$61M	$57M	$55M	$52M	$49M	$48M	$46M	·	$42M	$42M	$39M	·	$35M
Accum. Depreciation	$41M	$40M	$38M	$41M	$39M	$37M	$35M	$32M	$30M	$28M	·	$25M	$23M	$21M	·	$18M
Other Non-current Assets	$8M	$7M	$7M	$7M	$6M	$6M	$3M	$3M	$3M	$3M	·	$4M	$4M	$4M	·	$4M
Total Assets	$536M	$636M	$688M	$522M	$592M	$615M	$669M	$514M	$511M	$313M	·	$308M	$351M	$370M	·	$459M
Accounts Payable	$12M	$10M	$11M	$9M	$6M	$8M	$11M	$4M	$3M	$6M	·	$2M	$5M	$6M	·	$6M
Current Liabilities	$72M	$92M	$86M	$82M	$76M	$90M	$96M	$86M	$81M	$88M	·	$61M	$72M	$65M	·	$68M
Capital Leases	$55M	$55M	$53M	$53M	$47M	$20M	$20M	$21M	$21M	$22M	·	$3M	$4M	$5M	·	$8M
Total Liabilities	$133M	$155M	$149M	$150M	$144M	$134M	$142M	$137M	$140M	$144M	·	$74M	$91M	$96M	·	$117M
Common Stock	$104.0K	$103.0K	$102.0K	$77.0K	$76.0K	$76.0K	$76.0K	$67.0K	$64.0K	$49.0K	·	$49.0K	$48.0K	$47.0K	·	$47.0K
Retained Earnings	$-1.18B	$-1.09B	$-1.00B	$-925M	$-839M	$-795M	$-739M	$-680M	$-631M	$-587M	·	$-503M	$-466M	$-442M	·	$-355M
AOCI	$-145.0K	$56.0K	$105.0K	$119.0K	$-20.0K	$226.0K	$150.0K	$344.0K	$-135.0K	$-350.0K	·	$-1M	$-2M	$-3M	·	$-4M
Stockholders' Equity	$403M	$481M	$539M	$372M	$448M	$481M	$527M	$377M	$371M	$169M	$200M	$234M	$260M	$274M	$304M	$343M
Liabilities + Equity	$536M	$636M	$688M	$522M	$592M	$615M	$669M	$514M	$511M	$313M	·	$308M	$351M	$370M	·	$459M
Shares Outstanding	103,701,511	103,399,813	101,807,484	76,872,686	76,433,664	76,234,799	75,870,718	67,083,523	64,356,535	49,136,954	·	48,503,768	47,631,208	47,444,853	·	47,147,781

Arus Kas 10

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	·	$2M	$2M	$2M	$2M	$2M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Stock-based Comp	·	$9M	$9M	$10M	$10M	$9M	$9M	$9M	$9M	$8M	$8M	$8M	$9M	$8M	$8M	$7M
Operating Cash Flow	·	$-72M	$-68M	$-57M	$-63M	$-61M	$-49M	$-42M	$-40M	$-42M	$27M	$-41M	$-18M	$-48M	$-38M	$-46M
CapEx	·	$1M	$5M	$3M	$3M	$3M	$2M	$2M	$2M	$3M	$3M	$2M	$1M	$2M	$3M	$3M
Investing Cash Flow	·	$-124M	$346.0K	$50M	$71M	$26M	$-141M	$-21M	$-131M	$36M	$-14M	$23M	$44M	$16M	$55M	$-63M
Stock Issued	·	$18M	$0	$0	·	$0	$199M	$42M	·	·	$0	$0	·	·	$0	·
Net Stock Activity	·	$18M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	·	$20M	$236M	$1M	$6.0K	$1M	$201M	$46M	$238M	$2M	$7.0K	$2M	$25.0K	$1M	$-135.0K	$115M
Net Change in Cash	·	$-176M	$169M	$-6M	$8M	$-34M	$11M	$-18M	$67M	$-5M	$12M	$-17M	$25M	$-31M	$17M	$6M
Free Cash Flow	·	$-73M	·	·	·	$-65M	·	·	·	$-45M	·	·	·	$-51M	·	·

Profitabilitas 7

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1041.7%	-1479.4%	·	-1157.6%	-109.7%	-340.7%	·	-433.8%	-401.4%	-272.7%	·	-216.7%	-87.2%	-338.6%	·	-432.9%
Net Margin	-990.1%	-1394.3%	·	-1094.8%	-98.7%	-305.4%	·	-388.9%	-368.4%	-250.3%	·	-200.3%	-79.1%	-321.1%	·	-423.6%
Pretax Margin	-993.1%	·	·	-1094.8%	-96.9%	-305.4%	·	-388.3%	-367.6%	-249.8%	·	·	·	·	·	-423.6%
EBITDA Margin	-1041.7%	-1479.4%	·	-1157.6%	-109.7%	-340.7%	·	-433.8%	-401.4%	-272.7%	·	-216.7%	-87.2%	-338.6%	·	-432.9%
ROA	-15.9%	·	·	-16.7%	-7.9%	-12.2%	·	-11.9%	-10.3%	-12.2%	·	-9.6%	-6.5%	-10.1%	·	-9.6%
ROE	-21.1%	·	·	-23.1%	-10.6%	-17.3%	·	-16.0%	-14.1%	-18.8%	·	-12.8%	-9.2%	-14.1%	·	-12.7%
ROIC	-23.3%	·	·	-24.6%	-11.0%	-13.1%	·	-14.5%	-13.1%	-26.9%	·	·	·	·	·	-13.6%

Likuiditas & Solvabilitas 2

Metrik	Tren	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		6.3	·	·	5.4	6.8	6.3	·	5.3	5.6	2.9	·	4.4	4.0	4.4	·	5.3
Quick Ratio		0.9	·	·	1.0	1.4	0.8	·	1.1	1.4	0.6	·	4.2	3.9	4.3	·	5.1

Efisiensi 2

Metrik	Tren	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	·	·	0.0	0.1	0.0	·	0.0	0.0	0.0	·	0.0	0.1	0.0	·	0.0
Receivables Turnover		·	·	·	·	4.1	·	·	·	·	·	·	18.5	·	·	·	·

Per Saham 6

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$3.88	·	·	$4.84	$5.86	$6.31	·	$5.62	$5.76	$3.43	·	$4.82	$5.46	$5.78	·	$7.27
Revenue / Share	$0.08	$0.06	·	$0.09	$0.53	$0.22	·	$0.17	$0.19	$0.30	·	$0.34	$0.57	$0.23	·	$0.21
Cash Flow / Share	·	$-0.65	·	·	·	$-0.73	·	·	·	$-0.76	·	·	·	$-0.90	·	·
Cash / Share	$0.65	·	·	$1.02	$1.10	$1.00	·	$1.48	$1.81	$1.01	·	$0.87	$1.24	$0.71	·	$1.01
Dividend / Share	·	$0.00	$0.00	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00
EPS (TTM)	$-3.46	$-3.17	·	·	·	·	·	$-2.91	$-2.92	$-2.66	·	$-2.73	$-2.95	$-3.51	·	$-3.71

Valuasi (TTM) 9

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$37M	$77M	·	·	·	·	·	$56M	$62M	$81M	·	$69M	$61M	$42M	·	$39M
Net Income TTM	·	$-273M	·	·	·	·	·	$-177M	$-165M	$-145M	·	$-149M	$-157M	$-179M	·	$-171M
Market Cap	$1.84B	·	·	$718M	$812M	$1.18B	·	$1.69B	$1.01B	$607M	·	$412M	$482M	$447M	·	$742M
P/E	-5.1	-5.3	·	·	·	·	·	-8.7	-5.4	-4.6	·	-3.1	-3.4	-2.7	·	-4.2
P/S	50.1	·	·	·	·	·	·	30.0	16.3	7.5	·	6.0	7.9	10.7	·	18.9
P/B	4.6	·	·	1.9	1.8	2.4	·	4.5	2.7	3.6	·	1.8	1.9	1.6	·	2.2
P / Tangible Book	4.6	·	·	1.9	1.8	2.4	·	4.5	2.7	3.6	·	1.8	1.9	1.6	·	2.2
P / Cash Flow	·	·	·	·	·	-19.3	·	·	·	-14.5	·	·	·	-9.2	·	·
Earnings Yield	-19.5%	-18.9%	·	·	·	·	·	-11.6%	-18.5%	-21.5%	·	-32.1%	-29.1%	-37.2%	·	-23.6%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16

Metrik	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Pendapatan	$84M	$55M	$77M	$39M	$30M
Margin Operasi %	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%
Laba Bersih	$-264M	$-194M	$-144M	$-180M	$-117M
EPS Dilusian	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73

Metrik	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Rasio Lancar	7.0	6.5	3.4	4.5	4.7
Rasio Cepat	2.9	1.1	0.6	4.4	4.6

Metrik	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Arus Kas Bebas	$-263M	$-182M	$-90M	$-172M	$-90M

Pemilik institusional (13F) 223 pengaju · $2.8B total · Per tanggal 30 Sep. 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 223

Nilai yang dipegang $2.8B

Posisi baru 47

Posisi yang keluar 26

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya

Posisi baru	Posisi yang keluar	Meningkat	Menurun	Perubahan bersih saham
47 (+3 vs Kuartal sebelumnya)	26 (0 vs Kuartal sebelumnya)	67 (-2 vs Kuartal sebelumnya)	63 (+20 vs Kuartal sebelumnya)	-283K

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi	Nilai	Saham	% dari 13F yang dilacak	Tipe
BlackRock, Inc.	$212.768.666	8.770.349	7,57%	Saham
Vestal Point Capital, LP	$195.293.000	8.050.000	6,95%	Saham
Deep Track Capital, LP	$187.686.398	7.736.455	6,68%	Saham
Rubric Capital Management LP	$175.345.894	7.227.778	6,24%	Saham
FMR LLC	$133.071.325	5.485.215	4,73%	Saham
MORGAN STANLEY	$115.537.879	4.762.484	4,11%	Saham
STATE STREET CORP	$113.469.939	4.677.244	4,04%	Saham
BAKER BROS. ADVISORS LP	$113.016.569	4.658.556	4,02%	Saham
VANGUARD GROUP INC	$112.862.243	5.949.512	4,01%	Saham
VANGUARD CAPITAL MANAGEMENT LLC	$109.061.534	4.495.529	3,88%	Saham
PERCEPTIVE ADVISORS LLC	$104.813.438	4.320.422	3,73%	Saham
Redmile Group, LLC	$98.830.073	4.073.787	3,51%	Saham
GENERAL ATLANTIC, L.P.	$73.560.808	3.032.185	2,62%	Saham
GEODE CAPITAL MANAGEMENT, LLC	$61.566.526	2.537.291	2,19%	Saham
Pictet Asset Management Holding SA	$57.040.888	2.351.232	2,03%	Saham
ARK Investment Management LLC	$43.502.930	1.793.196	1,55%	Saham
Capital World Investors	$43.374.842	1.787.916	1,54%	Saham
Trails Edge Capital Partners, LP	$38.166.318	1.573.220	1,36%	Saham
VANGUARD PORTFOLIO MANAGEMENT LLC	$35.974.208	1.482.861	1,28%	Saham
CITADEL ADVISORS LLC	$35.832.481	1.477.019	1,27%	Saham
Soleus Capital Management, L.P.	$35.544.854	1.465.163	1,26%	Saham
DIMENSIONAL FUND ADVISORS LP	$34.720.069	1.431.317	1,23%	Saham
EVENTIDE ASSET MANAGEMENT, LLC	$31.486.884	1.297.893	1,12%	Saham
BRAIDWELL LP	$31.217.016	1.286.769	1,11%	Saham
Kynam Capital Management, LP	$28.984.805	1.194.757	1,03%	Saham
Woodline Partners LP	$25.812.786	1.064.006	0,92%	Saham
Sumitomo Mitsui Trust Group, Inc.	$23.858.788	983.462	0,85%	Saham
Amova Asset Management Americas, Inc.	$23.848.954	983.462	0,85%	Saham
Affinity Asset Advisors, LLC	$23.474.461	967.620	0,83%	Saham
UBS Group AG	$22.249.259	917.117	0,79%	Saham
NORTHERN TRUST CORP	$21.253.458	876.070	0,76%	Saham
BANK OF AMERICA CORP /DE/	$20.429.079	842.089	0,73%	Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$20.215.761	833.296	0,72%	Saham
Nuveen, LLC	$20.034.709	825.833	0,71%	Saham
GOLDMAN SACHS GROUP INC	$19.737.670	813.589	0,70%	Saham
KENNEDY CAPITAL MANAGEMENT LLC	$17.576.564	724.508	0,63%	Saham
VANGUARD FIDUCIARY TRUST CO	$16.650.560	686.338	0,59%	Saham
Rhenman & Partners Asset Management AB	$16.599.905	684.250	0,59%	Saham
RAYMOND JAMES FINANCIAL INC	$14.392.512	593.262	0,51%	Saham
Sofinnova Investments, Inc.	$12.714.617	524.098	0,45%	Saham
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$11.575.441	477.141	0,41%	Saham
Elmind Capital, LP	$11.159.600	460.000	0,40%	Saham
CITIGROUP INC	$9.446.456	389.384	0,34%	Saham
Candriam S.C.A.	$9.159.082	377.902	0,33%	Saham
Fisher Asset Management, LLC	$8.963.219	369.465	0,32%	Saham
JACOBS LEVY EQUITY MANAGEMENT, INC	$8.821.009	363.603	0,31%	Saham
FIRST TRUST ADVISORS LP	$8.754.172	360.848	0,31%	Saham
BNP PARIBAS FINANCIAL MARKETS	$8.262.422	340.578	0,29%	Saham
WELLINGTON MANAGEMENT GROUP LLP	$8.106.188	334.138	0,29%	Saham
ArrowMark Colorado Holdings LLC	$7.636.126	314.762	0,27%	Saham

Tampilkan semua 223 pemilik institusional →

Orang dalam perusahaan 20 orang dalam · 6 pejabat · 11 direktur

19

Orang Dalam	Peran	Aktivitas terakhir	Saham dimiliki	Jual 12m	Bersih 12m
Arthur T Sands	President, CEO	10 Feb. 2026 A	·	0	$0
Hans Van Houte	Chief Financial Officer	4 Agu 2026 S	40.166	10	$-635.401
Stefani Wolff	EVP and COO	30 April 2023 M	6.113	0	$0
Christine Ring	Chief Legal Officer	2 Okt. 2026 M	9.110	21	$-3.398.693
Gwenn Hansen	Chief Scientific Officer	1 Sep. 2026 M	117.227	10	$-630.908
Pierre Beaurang	Chief Business Officer	10 Agu 2021 M	4.330	0	$0
Edward C Saltzman	Direktur	15 Mei 2026 A	·	0	$0
Roger D Dansey	Direktur	15 Mei 2026 A	·	0	$0
David L. Lacey	Direktur	15 Mei 2026 A	·	0	$0
Anil Kapur	Direktur	15 Mei 2026 A	·	0	$0
Roy D. Baynes	Direktur	15 Mei 2026 A	·	0	$0
Paul M Silva	Direktur	15 Mei 2026 A	·	0	$0
Lori Anne Kunkel	Direktur	19 Mei 2025 A	0	0	$0
Clay B Siegall	Direktur	5 Mei 2022 A	·	0	$0
Jeffrey K Tong	Direktur	6 Mei 2021 A	·	0	$0
Robert Tjian	Direktur	28 Juli 2020 C	124.999	0	$0
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.	Pemilik 10%	28 Juli 2020 C	784.313	0	$0
Judith A Reinsdorf	·	15 Mei 2026 A	·	0	$0
Julia P Gregory	·	15 Mei 2026 A	10.750	0	$0
Leon Chen	·	6 Mei 2021 A	·	0	$0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 41 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana	Bobot	Unit	Per tanggal	Sumber
ARKG · ARK ETF Trust	2,51%	1.682.054 NS	31 Juli 2026	N-PORT
PTH · Invesco Exchange-Traded Fund Trust	1,24%	153.433 SH	2 Okt. 2026	Harian
BBC · ETFis Series Trust I	0,92%	18.337 NS	31 Juli 2026	N-PORT
IWC · iShares Trust	0,59%	325.791 SH	11 Sep. 2026	Harian
LABU · Direxion Shares ETF Trust	0,39%	83.566 NS	31 Juli 2026	N-PORT
FYC · First Trust Exchange-Traded AlphaDE…	0,38%	212.938 NS	31 Juli 2026	N-PORT
DWAS · Invesco Exchange-Traded Fund Trust …	0,36%	62.236 SH	2 Okt. 2026	Harian
IBB · iShares Trust	0,19%	749.550 SH	11 Sep. 2026	Harian
IBBQ · Invesco Exchange-Traded Fund Trust …	0,16%	7.333 SH	2 Okt. 2026	Harian
IWO · iShares Trust	0,13%	693.157 SH	11 Sep. 2026	Harian
FYX · First Trust Exchange-Traded AlphaDE…	0,12%	71.916 NS	31 Juli 2026	N-PORT
FFSM · FIDELITY COVINGTON TRUST	0,11%	71.221 NS	31 Juli 2026	N-PORT
PWS · Pacer Funds Trust	0,11%	1.142 NS	31 Juli 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0,11%	79.174 SH	19 Agu 2026	Harian
PRFZ · Invesco Exchange-Traded Fund Trust	0,09%	103.798 SH	2 Okt. 2026	Harian
IWM · iShares Trust	0,08%	2.461.076 SH	11 Sep. 2026	Harian
FAD · First Trust Exchange-Traded AlphaDE…	0,08%	19.290 NS	31 Juli 2026	N-PORT
RSSL · Global X Funds	0,07%	45.904 NS	31 Juli 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,07%	551.605 SH	19 Agu 2026	Harian
OMFS · Invesco Exchange-Traded Self-Indexe…	0,06%	6.461 SH	2 Okt. 2026	Harian
DFAS · Dimensional ETF Trust	0,05%	313.021 NS	31 Juli 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,03%	1.114.166 SH	19 Agu 2026	Harian
VTWV · VANGUARD SCOTTSDALE FUNDS	0,03%	19.327 SH	19 Agu 2026	Harian
ISCG · iShares Trust	0,03%	9.673 SH	11 Sep. 2026	Harian
FHLC · FIDELITY COVINGTON TRUST	0,02%	29.479 NS	31 Juli 2026	N-PORT
VHT · VANGUARD WORLD FUND	0,02%	186.845 SH	19 Agu 2026	Harian
WSML · iShares Trust	0,02%	4.261 SH	11 Sep. 2026	Harian
TILT · FlexShares Trust	0,01%	8.908 NS	31 Juli 2026	N-PORT
DFAC · Dimensional ETF Trust	0,01%	181.202 NS	31 Juli 2026	N-PORT
DCOR · Dimensional ETF Trust	0,01%	7.762 NS	31 Juli 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	21.135 NS	31 Juli 2026	N-PORT
ITOT · iShares Trust	0,00%	136.268 SH	11 Sep. 2026	Harian
IWV · iShares Trust	0,00%	27.695 SH	11 Sep. 2026	Harian
DFSU · Dimensional ETF Trust	0,00%	3.425 NS	31 Juli 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	16.122 NS	31 Juli 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	3.275.161 SH	19 Agu 2026	Harian
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	7.909 SH	19 Agu 2026	Harian
IWN · iShares Trust	·	210.645 SH	11 Sep. 2026	Harian
ISCB · iShares Trust	·	3.438 SH	11 Sep. 2026	Harian
ISCV · iShares Trust	·	10.240 SH	11 Sep. 2026	Harian
SMLF · iShares Trust	·	88.041 SH	11 Sep. 2026	Harian

NRIX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21

peringkat · 21 analis BELI

Target median $34.00 +47,9%

7 33,3% Beli Kuat

12 57,1% Beli

2 9,5% Tahan

0 0,0% Jual

0 0,0% Jual Kuat

Target Harga 12 Bulan

14 analis · 2026-09-29

Target rata-rata $33.93 +47,6%

← Di bawah semua target Harga saat ini $22.99

Rendah$25.00 Rata-rata$33.93 Tinggi$45.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
NRIX	$1.80B	-5.8	53.9%	-314.9%	-53.6%	·
PURR	$1.58B	2.5	·	3229.8%	24.8%	·
BEAM	$2.82B	-34.2	120.0%	-57.2%	-7.0%	·
IRON	$3.01B	-13.2	·	·	-31.3%	·
CLDX	$1.81B	-7.0	-78.0%	-16748.0%	-43.8%	·
IMNM	$2.43B	-8.8	-23.2%	-3060.0%	-47.0%	·
SLS	$577M	-15.1	·	·	-55.4%	·
VRDN	$3.17B	-7.7	23359.9%	-483.6%	-55.4%	·
RXRX	$2.16B	-2.8	26.9%	-863.4%	-62.9%	·

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23

Roche And Nurix Ink $2.3 Bln Collaboration To Co-Develop BTK Degrader Bexobrutideg Nasdaq · 3 bulan, 3 minggu lalu Nurix Therapeutics Melaporkan Kerugian Lebih Besar di Q1 Nasdaq · 5 bulan, 3 minggu lalu

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

NRIX Nurix Therapeutics, Inc. - Common stock